[DTPA-(PABn)-Leu5]-des-acyl ghrelin(1–5) as a new carrier of radionuclides and potential precursor of radiopharmaceuticals
Conclusion
The results obtained suggest the potency of the [DTPA-(PABn)-Leu5]-DAG(1–5) as a new carrier of radionuclides in radiopharmacy.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Hormones | Iodine | Nuclear Medicine | Prostate Cancer | Study